FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/091125 [Registered on: 18/07/2025] Trial Registered Prospectively
Last Modified On: 05/08/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Medical Device 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   This study compares two settings of the breathing machine, ASV and PSV, to help ICU patients breathe on their own. ASV adjusts support automatically based on the patients needs, while PSV provides pressure based support that is manually adjusted. 
Scientific Title of Study   Comparison of Adaptive Support Ventilation and Pressure Support Ventilation for Weaning and Extubation Outcomes in Critically Ill Patients in an Indian ICU: A Prospective Randomized Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Devshankar Moosad E I 
Designation  Jr. Clinical Assistant 
Affiliation  Christian Medical College, Vellore 
Address  Surgical ICU, Christian Medical college, Vellore, Tamilnadu.

Vellore
TAMIL NADU
632002
India 
Phone  6282903775  
Fax    
Email  devshankar.moosad@cmcvellore.ac.in  
 
Details of Contact Person
Scientific Query
 
Name  George Prashanth Kurian 
Designation  Consultant Surgical ICU 
Affiliation  Christian medical college, Vellore 
Address  Surgical ICU, Christian Medical college, Vellore, Tamilnadu

Vellore
TAMIL NADU
632002
India 
Phone  9655594316  
Fax    
Email  georgekurian14@gmail.com  
 
Details of Contact Person
Public Query
 
Name  George Prashanth Kurian 
Designation  Consultant Surigical ICU 
Affiliation  Christian medical college, Vellore 
Address  Surgical ICU, Christian Medical college, Vellore, Tamilnadu

Vellore
TAMIL NADU
632002
India 
Phone  9655594316  
Fax    
Email  georgekurian14@gmail.com  
 
Source of Monetary or Material Support  
Fluid research fund, Christian Medical College, Vellore, Tamil Nadu, India. Pin: 632002  
 
Primary Sponsor  
Name  Christian Medical College Vellore Tamilnadu India 
Address  Christian Medical College, Vellore, Tamilnadu, India. Pin: 632002 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Devshankar moosad E I  Christian Medical College, Vellore  Surgical ICU, Christian Medical College, Vellore Tamilnadu 632002
Vellore
TAMIL NADU 
6282903775

devshankar.moosad@cmcvellore.ac.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Christian medical college instituitional Ethic committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Adaptive support ventilation  ASV is an intelligent ventilator mode that automatically adjusts the level of breathing support based on the patients lung condition and effort to promote safe and efficient weaning. Duration: Till time of extubation, when the patient has got positive spontaneous breathing test (SBT) 
Comparator Agent  Pressure support ventialtion  PSV is a ventilator mode where the patient initiates breaths and the machine provides a fixed pressure boost, manually set by clinicians, to reduce the work of breathing. Duration: Till time of extubation, when the patient has got positive spontaneous breathing test (SBT) 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  Mechanical ventilation for at least 24 hrs
Patients with APACHE II score of 5 - 20
 
 
ExclusionCriteria 
Details  a) Mechanical ventilation for less than 24 hours (including self extubation or death).

b) Patients with Coexisting severe Neurological/ Neuromuscular/Quadriplegia/Critical illness neuropathy/ Critical illness Myopathy/ Myasthenia gravis/ Guillain Barre syndrome or cardiac diseases as it may prolong weaning for extra-pulmonary reasons.

c) Pregnancy
 
 
Method of Generating Random Sequence   Permuted block randomization, variable 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Incidence of successful weaning
 
48 hrs after extubation
 
 
Secondary Outcome  
Outcome  TimePoints 
1. Time to Successful Extubation, Duration from initiation of weaning to successful extubation.
2. Total Duration of Mechanical Ventilation, Time from intubation to final extubation
3. ICU Length of Stay, Total duration of ICU stay post initiation of weaning.
4. Mortality, ICU mortality rates.
5. Number of manual ventilator aadjustments & ABG sampling required in each group
6. VAP Incidence rate
 
1. baseline & 48hrs after extubation
2. at the time of extubation
3. at the time of discharge
4. at any point of the study after baseline.
5. at the time of extubation
6. at the time of extubation 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   28/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Study Title
Comparison of Adaptive Support Ventilation and Pressure Support Ventilation for Weaning and Extubation Outcomes in Critically Ill Patients in an Indian ICU – A Prospective Randomized Study

Study Summary
This prospective randomized study compares the effectiveness of Adaptive Support Ventilation ASV and Pressure Support Ventilation PSV in weaning critically ill patients from mechanical ventilation. The study population includes surgical and trauma patients with medical comorbidities. Previous studies have shown different outcomes between medical and surgical ICU patients under similar protocols.

Inclusion Criteria

Age above 18 years

Mechanically ventilated for 24 hours or more

APACHE II score between 5 and 30


Exclusion Criteria

Severe neurological or cardiac conditions

Pregnant women


Patients will be enrolled once their acute illness has resolved and the clinical team decides to start weaning. Consent will be obtained from the next of kin. Randomization will be done using permuted block randomization with concealed allocation through opaque sealed envelopes. Patients will be assigned to either ASV or PSV.

Weaning Criteria

Reversal of initial cause for ventilation

Hemodynamic stability with heart rate less than 120 and respiratory rate less than 35

pH greater than 735, tidal volume more than 5 ml per kg, minute volume less than 10 liters per minute

PEEP less than 5 cm H2O, PaO2 greater than 60 mmHg with FiO2 less than 0.4, and PaO2 to FiO2 ratio greater than 150


A standard ICU extubation protocol will be followed. Patients will be considered for extubation when they meet readiness criteria such as:

Hemodynamic stability with minimal or no vasopressors

Adequate oxygenation with PaO2 to FiO2 ratio above 150 to 200 and SpO2 above 92 percent on 40 percent FiO2 or less

Protective airway reflexes like cough and gag

Adequate mental status and ability to protect airway

Successful completion of a spontaneous breathing trial


All other ICU management including sedation, investigations, and resuscitation will be uniform across both groups. Most extubations will occur between 7 AM and 7 PM due to staff availability and institutional safety protocols. This timing is consistent across both groups and does not introduce bias.

Primary Outcome
Successful weaning defined as a composite of:

No need for reintubation within 48 hours

If NIV is needed, HACOR score less than 5

If HFNC is needed, ROX index greater than 285 at 2 hours


Secondary Outcomes

Total duration of mechanical ventilation

Time to successful extubation

ICU length of stay

ICU mortality

Number of manual ventilator adjustments

Number of ABG analyses required

Rate of ventilator associated pneumonia


This study aims to identify the better ventilatory strategy for improving weaning and extubation outcomes in surgical ICU patients.

 
Close